12:00 AM
Apr 24, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Vasomax phentolamine mesylate: Update

Zonagen Inc. (ZONA), The Woodlands, Texas
Product: Vasomax phentolamine mesylate
Business: Urological
Therapeutic category: Vasodilation
Target: Alpha adrenergic receptors
Description: Oral nonspecific alpha adrenergic receptor inhibitor
Indication: Treat erectile...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >